Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffoldin Vitro
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffoldin Vitro
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 5, Pages 1876-1883
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2016-12-23
DOI
10.1074/jbc.m116.748707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineering an IgG Scaffold Lacking Effector Function with Optimized Developability
- (2016) Frederick W. Jacobsen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics
- (2014) Man-Seok Ju et al. CURRENT OPINION IN BIOTECHNOLOGY
- Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
- (2013) Maya K Leabman et al. mAbs
- Unexpected Hematologic Effects of Biotherapeutics in Nonclinical Species and in Humans
- (2013) Nancy E. Everds et al. TOXICOLOGIC PATHOLOGY
- Unexpected Thrombocytopenia and Anemia in Cynomolgus Monkeys Induced by a Therapeutic Human Monoclonal Antibody
- (2013) Nancy Everds et al. TOXICOLOGIC PATHOLOGY
- Effect of pH, Temperature, and Salt on the Stability of Escherichia coli- and Chinese Hamster Ovary Cell-Derived IgG1 Fc
- (2012) Cynthia H. Li et al. BIOCHEMISTRY
- Different Adaptations of IgG Effector Function in Human and Nonhuman Primates and Implications for Therapeutic Antibody Treatment
- (2012) M. Warncke et al. JOURNAL OF IMMUNOLOGY
- Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody
- (2012) Michael J. Santostefano et al. TOXICOLOGIC PATHOLOGY
- Recent developments in engineering and delivery of protein and antibody therapeutics
- (2011) Luis Ángel Fernández et al. CURRENT OPINION IN BIOTECHNOLOGY
- Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
- (2011) Sang Taek Jung et al. CURRENT OPINION IN BIOTECHNOLOGY
- Isolation and characterization of IgG1 with asymmetrical Fc glycosylation
- (2011) S. Ha et al. GLYCOBIOLOGY
- A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients
- (2010) Takahiro Ishiguro et al. CANCER SCIENCE
- Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals
- (2010) Takashi Ishihara et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Molecular and Functional Characterization of Cynomolgus Monkey IgG Subclasses
- (2010) F. W. Jacobsen et al. JOURNAL OF IMMUNOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates
- (2010) Heather Franey et al. PROTEIN SCIENCE
- CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
- (2009) F. T. Awan et al. BLOOD
- Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
- (2009) Akito Natsume et al. CANCER SCIENCE
- Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
- (2009) Tanja Schneider-Merck et al. JOURNAL OF IMMUNOLOGY
- Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
- (2009) Royston Jefferis TRENDS IN PHARMACOLOGICAL SCIENCES
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started